SCA Pharma, an FDA-registered outsourcing facility, is expanding its operations in Little Rock. SCA will be investing more than $10 million and will create the opportunity to double its current Little Rock workforce of 180 people. 
 
Additionally, the investment will allow SCA Pharma to renovate an existing 42,000-square-foot facility at the Clinton National Airport and construct an additional 20,000-square-foot facility adjacent to the existing facility. SCA also plans a 40 percent expansion of its Windsor, Conn. facility.
 
“We are very pleased that as we continue our geographical expansions in both Arkansas and Connecticut, we can partner with the Arkansas Economic Development Commission (AEDC) and the Little Rock Municipal Airport Commission to solidify and expand the operations of our legacy operations,” said Milton Boyer, CEO of SCA Pharma. “Little Rock has been the foundation that has allowed for our other expansion projects, and this project will bolster that foundation for years to come.”
 
SCA says it has experienced significant growth over the past five years and believes that creating an additional clean room capacity will provide another avenue to increase supply.
 
“Arkansas is committed to nurturing its homegrown companies from seed stage upward,” gov. Asa Hutchinson said. “We are proud to see the success that SCA Pharma is experiencing and look forward to the products and services being developed here in central Arkansas that will positively impact the lives of people around the country.”
 
The expansion of both locations will also create the need for technical and highly skilled jobs for both areas.
 
“Even in these trying and turbulent times of a global pandemic and its uncertainty, Little Rock is continuing to see companies invest and create new jobs for our citizens,” said Mayor Frank Scott Jr. “We are thrilled and grateful SCA Pharma is joining Little Rock’s momentum and creating high-paying jobs that will have a lasting impact on our economy.”